# Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/oral-mucosal-cannabinoid-delivery-formulation-bioavailability/ > **Published:** 2026-04-27T04:03:07-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:01:37-04:00 > **Clinical Summary:** Explore oral mucosal cannabinoid delivery methods to enhance bioavailability and therapeutic effects of cannabinoids like CBD and THC. --- CED Clinical Relevance  #74Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic Journal AAPS PharmSciTech Study Type Clinical Study Population Human participants Why This Matters This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and clinical practice. Clinicians monitoring evidence in this area should review the source material. Clinical Summary Cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) have garnered significant interest for their broad-spectrum pharmacological activity in managing [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), neurological disorders, and cancer-associated symptoms. Despite their therapeutic promise, clinical translation remains hindered by poor aqueous solubility, extensive first-pass metabolism, and inconsistent systemic exposure following oral administration. Oral mucosal [drug delivery](https://cedclinic.com/cannabinoid-oral-mucosal-delivery-formulation-fabrication/) systems offer a viable alternative by enabling transmucosal absorption, bypassing hepatic metabolism, and facilitating both rapid and sustained drug release. This review examines the evolution and design of oral mucosal dosage forms, including fast-dissolving films, mucoadhesive matrices, in situ gels, and particulate systems and highlights the critical role of formulation strategies in enhancing [cannabinoid bioavailability](https://cedclinic.com/cannabis-beverage-market-united-center-partnership/). Fabrication techniques such as solvent casting, hot melt extrusion, and emerging 3D printing methods are al Dr. Caplan’s Take “This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.” Clinical Perspective 🧠 Clinicians should review this item in the context of their current practice and patient population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabinoid%20Oral%20Mucosal%20Delivery%3A%20Approaches%20to%20Formulation%2C%20Fabrication%2C%20and%20Permeation%20Enhancemen...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-oral-mucosal-delivery-approaches-to-formulation-fabrication-and%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-oral-mucosal-delivery-approaches-to-formulation-fabrication-and%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabinoid%20Oral%20Mucosal%20Delivery%3A%20Approaches%20to%20Formulation%2C%20Fabrication%2C%20and%20Permeation%20Enhancemen...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fcannabinoid-oral-mucosal-delivery-approaches-to-formulation-fabrication-and%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41792583/](https://pubmed.ncbi.nlm.nih.gov/41792583/) Table of Contents - [FAQ](#FAQ)[For which health problems are CBD and THC of therapeutic interest?](#For_which_health_problems_are_CBD_and_THC_of_therapeutic_interest) - [Why is it hard to get cannabinoids into the body when swallowed?](#Why_is_it_hard_to_get_cannabinoids_into_the_body_when_swallowed) - [How could delivery through the lining of the mouth help?](#How_could_delivery_through_the_lining_of_the_mouth_help) - [What types of oral mucosal cannabinoid products does the review cover?](#What_types_of_oral_mucosal_cannabinoid_products_does_the_review_cover) - [How are oral mucosal cannabinoid products manufactured?](#How_are_oral_mucosal_cannabinoid_products_manufactured) - [Related](#Related) ## FAQ ### For which health problems are CBD and THC of therapeutic interest? According to the review, CBD and THC have drawn significant interest for their broad pharmacological activity in managing [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), neurological disorders, and cancer-associated symptoms. The review frames this as therapeutic promise whose clinical translation still faces hurdles, which is what motivates the search for better ways to deliver these compounds. ### Why is it hard to get cannabinoids into the body when swallowed? The review describes three main problems with oral administration of cannabinoids: poor solubility in water, extensive first-pass metabolism, and inconsistent systemic exposure, meaning the amount that reaches the bloodstream varies. These issues have hindered the move from therapeutic promise to clinical use. ### How could delivery through the lining of the mouth help? Oral mucosal delivery systems allow cannabinoids to be absorbed through the lining of the mouth. The review describes this as a viable alternative to swallowing because it bypasses metabolism in the liver and can support both rapid and sustained drug release. ### What types of oral mucosal cannabinoid products does the review cover? The review examines the evolution and design of several oral mucosal dosage forms, including fast-dissolving films, mucoadhesive matrices, in situ gels, and particulate systems. It highlights the critical role that formulation strategies play in enhancing [cannabinoid bioavailability](https://cedclinic.com/cannabis-beverage-market-united-center-partnership/). ### How are oral mucosal cannabinoid products manufactured? The review names solvent casting, hot melt extrusion, and emerging 3D printing methods as fabrication techniques for oral mucosal cannabinoid dosage forms. These manufacturing methods are covered in the review in addition to its discussion of formulation strategies and dosage form design. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Can Mouth-Dissolving Films and Gels Solve Cannabis Medicine’s Bioavailability Problem?](https://cedclinic.com/oral-mucosal-cannabinoid-bioavailability-review/) Review the latest advances in mouth-dissolving films and gels designed to improve cannabinoid bioavailability through oral mucosal delivery. [Learn More](https://cedclinic.com/oral-mucosal-cannabinoid-bioavailability-review/) [What Cannabis Does to Your Brain in the First 24 Hours – Verywell Health](https://cedclinic.com/cannabis-brain-effects-evidence-first-24-hours/) Understand the immediate effects of cannabis on brain function within the first 24 hours of use. [Read Article](https://cedclinic.com/cannabis-brain-effects-evidence-first-24-hours/) [Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) Explore evidence showing how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) can reduce reliance on opioids and other prescription medications. [Explore Findings](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).